Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#GlobalHIVHumanimmunodeficiencyVirusTherapeuticsMarket–Technavio has been monitoring the HIV therapeutics market and it is poised to grow by USD 2.44 billion during…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Chief Executive Officer John Higgins issued a letter to Ligand’s Captisol®…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Chief Executive Officer John Higgins issued a letter to Ligand’s Captisol®…
LONDON–(BUSINESS WIRE)–#GlobalProteinuriaTherapeuticsMarket–Technavio has been monitoring the global proteinuria therapeutics market size and it is poised to grow by USD 81.83…
LONDON–(BUSINESS WIRE)–#GlobalProteinuriaTherapeuticsMarket–Technavio has been monitoring the global proteinuria therapeutics market size and it is poised to grow by USD 81.83…
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
LONDON–(BUSINESS WIRE)–#GlobalIdiopathicIntracranialHypertensionTherapeuticsMarket–Technavio has been monitoring the idiopathic intracranial hypertension therapeutics market and it is poised to grow by USD 15.34…
LONDON–(BUSINESS WIRE)–#GlobalIdiopathicIntracranialHypertensionTherapeuticsMarket–Technavio has been monitoring the idiopathic intracranial hypertension therapeutics market and it is poised to grow by USD 15.34…
LONDON–(BUSINESS WIRE)–#GlobalWestNileVirusTherapeuticsMarket–Technavio has been monitoring the West Nile virus therapeutics market and it is poised to grow by USD 23.46…